PTO Hit With Second Lawsuit Opposing Continuation Rules As GSK Joins Fray
Executive Summary
GlaxoSmithKline has filed suit against the Patent and Trademark Office to block new rules limiting the number of continuation applications a patent holder can file
You may also be interested in...
Legal Brawl Over Patent Rules Creates Wide Trenches As More Groups Weigh In
The legal battle over the U.S. Patent and Trademark Office's efforts to limit certain patent filings intensified last month as various parties jumped into the fray
Legal Brawl Over Patent Rules Creates Wide Trenches As More Groups Weigh In
The legal battle over the U.S. Patent and Trademark Office's efforts to limit certain patent filings intensified last month as various parties jumped into the fray
New Patent Rules May Hurt Biotech Industry; Limits Set On Certain Filings
The U.S. Patent and Trademark Office is implementing new rules on patent filings that will make it tougher for biotechnology companies to protect their inventions